Aligos Therapeutics, Inc. ALGS
ALGS
Aligos Therapeutics, Inc. CLTEF
Calliditas Therapeutics AB (publ) ACRV
Acrivon Therapeutics, Inc. Common Stock RLMD
Relmada Therapeutics, Inc. INMB
INmune Bio, Inc. NICXF
Nicox S.A. DTIL
Precision BioSciences, Inc. TPST
Tempest Therapeutics, Inc. ACET
Adicet Bio, Inc. RPTX
Repare Therapeutics Inc.
Aligos Therapeutics, Inc. CLTEF
Calliditas Therapeutics AB (publ) ACRV
Acrivon Therapeutics, Inc. Common Stock RLMD
Relmada Therapeutics, Inc. INMB
INmune Bio, Inc. NICXF
Nicox S.A. DTIL
Precision BioSciences, Inc. TPST
Tempest Therapeutics, Inc. ACET
Adicet Bio, Inc. RPTX
Repare Therapeutics Inc.
Performance
| Periode | ALGS | CLTEF | ACRV | RLMD | INMB | NICXF | DTIL | TPST | ACET | RPTX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 132.11 % | -78.03 % | 8.64 % | 570.12 % | -75.20 % | 20.00 % | 27.95 % | 71.76 % | 76.92 % | 103.33 % |
| YTD | -76.22 % | -78.03 % | -69.07 % | 339.95 % | -62.88 % | 25.00 % | 20.04 % | -4.27 % | -2.44 % | 38.64 % |
| 1Y | 30.98 % | -78.03 % | -75.76 % | 136.44 % | -63.98 % | -31.82 % | -36.81 % | -23.20 % | -31.16 % | -46.02 % |
| 3Y | -66.18 % | -89.93 % | -89.42 % | 22.23 % | -72.06 % | -83.05 % | -86.30 % | -48.64 % | -94.34 % | -85.53 % |
| 5Y | -97.45 % | -93.45 % | -89.42 % | -73.24 % | -80.76 % | -93.26 % | -97.31 % | -55.21 % | -93.21 % | -92.19 % |
| 10Y | -97.45 % | -93.45 % | -89.42 % | -38.12 % | -77.10 % | -96.88 % | -98.92 % | -99.56 % | -99.20 % | -94.06 % |
| From the beginning | -97.45 % | -93.45 % | -89.42 % | -83.50 % | -77.10 % | -99.25 % | -98.92 % | -99.37 % | -99.20 % | -94.06 % |